+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Non-Opioid Pain Patches Market 2020-2026

  • ID: 5145142
  • Report
  • July 2020
  • Region: Global
  • Orion Market Research Private Limited
UP TO OFF
until Dec 31st 2021

FEATURED COMPANIES

  • Acorda Therapeutics, Inc.
  • Alkermes plc
  • BioElectronics Corp.
  • Endo International plc
  • Mylan N.V.
  • Sanofi S.A.
Global Non-Opioid Pain Patches Market Size, Share & Trends Analysis Report, By Patch Type (Lidocaine Patches, Diclofenac Patches, Capsaicin Patches, Ketoprofen Patches, Others), By Distribution Channel (Hospitals, Online Pharmacies, and Drug Stores) and Forecast, 2020-2026.

The global non-opioid pain patches market is estimated to grow significantly during the forecast period. The rising number of people suffering from chronic pain and increasing ageing population is one of the major factors encouraging market growth. As per the Centers for Disease Control and Prevention (CDC), in 2016, an estimated 20.4% of the US adults were suffering from chronic pain and 8% of the US adults were suffering from high-impact chronic pain. Low back pain is one of the major causes of chronic pain in adults.

This is leading to increasing demand for non-opioid pain patches to reduce chronic pain. The lidocaine patch 5%, Lidoderm, is a topical local anesthetic. As compared to administering a drug through injection or taking an oral medication, this medication is infused into a patch that adheres to the skin. The medication enters the body through the skin, which works to decrease pain by blocking nerve signals. It may support relieve neuropathic chronic back and neck pain.

Geographically, in 2019, North America held the largest share in the market owing to the significant prevalence of chronic diseases and rising spine injuries in the region. As per the data published by the National Spinal Cord Injury Statistical Center, as of 2019, in the US, the annual incidence of spinal cord injury is approximately 54 cases per one million people, or nearly 17,730 new spinal cord injury cases each year. This may result in driving the demand for non-opioid pain patches for the management of neuropathic pain reported in patients with spinal cord injury.

Some key players in the market include Endo International plc, Sorrento Therapeutics, Inc., Hisamitsu Pharmaceutical Co., Inc., Acorda Therapeutics, Inc. Mergers and acquisitions, product launches, and partnerships and collaborations are considered as crucial strategies adopted by the market players to expand market share. For instance, in February 2020, BioElectronics declared that it has gained a new 510(k) clearance from the US FDA for its new, over-the-counter (OTC) drug-free ActiPatch medical device, for the adjunctive treatment of musculoskeletal pain. This device was already FDA-cleared for OTC treatment of pain from plantar fasciitis (heel pain) and knee osteoarthritis in 2017. This approval enhanced these indications by covering all musculoskeletal pain problems.

Research Methodology

The market study of the global non-opioid pain patches market is incorporated by extensive primary and secondary research conducted. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Non-Opioid Pain Patches Market Research and Analysis by Patch Type
2. Global Non-Opioid Pain Patches Market Research and Analysis by Distribution Channel

The Report Covers
  • Comprehensive research methodology of the global non-opioid pain patches market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global non-opioid pain patches market.
  • Insights about market determinants, which are stimulating the global non-opioid pain patches market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Acorda Therapeutics, Inc.
  • Alkermes plc
  • BioElectronics Corp.
  • Endo International plc
  • Mylan N.V.
  • Sanofi S.A.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Endo International plc
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Sorrento Therapeutics, Inc.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Hisamitsu Pharmaceutical Co., Inc.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Acorda Therapeutics, Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Sanofi S.A.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments

4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities

5. Market Segmentation
5.1. Global Non-Opioid Pain Patches Market by Patch Type
5.1.1. Lidocaine Patches
5.1.2. Diclofenac Patches
5.1.3. Capsaicin Patches
5.1.4. Ketoprofen Patches
5.1.5. Others
5.2. Global Non-Opioid Pain Patches Market by Distribution Channel
5.2.1. Hospitals
5.2.2. Online Pharmacies
5.2.3. Drug Stores

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Acorda Therapeutics, Inc.
7.2. AdhexPharma
7.3. Alkermes plc
7.4. Averitas Pharma, Inc.
7.5. BioElectronics Corp.
7.6. Ceramisphere Pty Ltd.
7.7. Endo International plc
7.8. GlaxoSmithKline plc
7.9. Hisamitsu Pharmaceutical Co., Inc.
7.10. IBSA Institut Biochimique SA
7.11. Mylan N.V.
7.12. Pfizer Inc.
7.13. Sanofi S.A.
7.14. Sorrento Therapeutics, Inc.
7.15. TEH SENG Pharmaceutical Mfg. Co., Ltd.
7.16. Teikoku Seiyaku Co. Ltd.
7.17. Teva Pharmaceuticals Industries Ltd.

LIST OF TABLES
1. GLOBAL NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY PATCH PATCH TYPE, 2019-2026 ($ MILLION)
2. GLOBAL LIDOCAINE PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
3. GLOBAL DICLOFENAC PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
4. GLOBAL CAPSAICIN PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
5. GLOBAL KETOPROFEN PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
6. GLOBAL OTHER NON-OPIOID PAIN PATCHESES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
7. GLOBAL NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2019-2026 ($ MILLION)
8. GLOBAL NON-OPIOID PAIN PATCHES FROM HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
9. GLOBAL NON-OPIOID PAIN PATCHES FROM ONLINE PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
10. GLOBAL NON-OPIOID PAIN PATCHES FROM DRUG STORES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
11. GLOBAL NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
12. NORTH AMERICAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
13. NORTH AMERICAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY PATCH TYPE, 2019-2026 ($ MILLION)
14. NORTH AMERICAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2019-2026 ($ MILLION)
15. EUROPEAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
16. EUROPEAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY PATCH TYPE, 2019-2026 ($ MILLION)
17. EUROPEAN NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2019-2026 ($ MILLION)
18. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
19. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY PATCH TYPE, 2019-2026 ($ MILLION)
20. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2019-2026 ($ MILLION)
21. REST OF THE WORLD NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY PATCH TYPE, 2019-2026 ($ MILLION)
22. REST OF THE WORLD NON-OPIOID PAIN PATCHES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2019-2026 ($ MILLION)

LIST OF FIGURES
1. GLOBAL NON-OPIOID PAIN PATCHES MARKET SHARE BY PATCH TYPE, 2019 VS 2026 (%)
2. GLOBAL NON-OPIOID PAIN PATCHES MARKET SHARE BY DISTRIBUTION CHANNEL, 2019 VS 2026 (%)
3. GLOBAL NON-OPIOID PAIN PATCHES MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
4. US NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
5. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
6. UK NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
7. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
8. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
9. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
10. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
11. ROE NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
12. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
13. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
14. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
15. REST OF ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
16. REST OF THE WORLD NON-OPIOID PAIN PATCHES MARKET SIZE, 2019-2026 ($ MILLION)
Note: Product cover images may vary from those shown
  • Acorda Therapeutics, Inc.
  • AdhexPharma
  • Alkermes plc
  • Averitas Pharma, Inc.
  • BioElectronics Corp.
  • Ceramisphere Pty Ltd.
  • Endo International plc
  • GlaxoSmithKline plc
  • Hisamitsu Pharmaceutical Co., Inc.
  • IBSA Institut Biochimique SA
  • Mylan N.V.
  • Pfizer Inc.
  • Sanofi S.A.
  • Sorrento Therapeutics, Inc.
  • TEH SENG Pharmaceutical Mfg. Co., Ltd.
  • Teikoku Seiyaku Co. Ltd.
  • Teva Pharmaceuticals Industries Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll